As 2026 commences, global health authorities are enforcing a transition from siloed electronic records to a unified longitudinal patient view. This evolution is driven by the recent World Health Assembly resolution aimed at eliminating data fragmentation that currently hinders emergency response and chronic care management. With the integration of advanced semantic layers, clinicians in major...

The Cell Line Development Market offers strong opportunities for biotechnology companies and pharmaceutical manufacturers as biologics continue to dominate the global drug pipeline. With increasing research in monoclonal antibodies, vaccines, and gene therapies, reliable cell line platforms are essential for consistent product manufacturing. Growing investments in life sciences research are...